VFA
TEVA icon

Valeo Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Valeo Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,456
Closed -$75K – 1691
2021
Q1 		$75K Sell
6,456
-1,400
-18% -$16.1K ﹤0.01% 712
2020
Q4 		$76K Buy
7,856
+4,350
+124% +$41.7K ﹤0.01% 644
2020
Q3 		$32K Hold
3,506
– – ﹤0.01% 796
2020
Q2 		$43K Hold
3,506
– – ﹤0.01% 789
2020
Q1 		$36K Buy
3,506
+800
+30% +$8.2K ﹤0.01% 709
2019
Q4 		$27K Sell
2,706
-165
-6% -$1.47K ﹤0.01% 851
2019
Q3 		$20K Buy
2,871
+1,400
+95% +$10.7K ﹤0.01% 852
2019
Q2 		$14K Buy
1,471
+264
+22% +$3.18K ﹤0.01% 940
2019
Q1 		$19K Hold
1,207
– – ﹤0.01% 810
2018
Q4 		$19K Sell
1,207
-330
-21% -$6.76K ﹤0.01% 726
2018
Q3 		$31K Buy
1,537
+224
+17% +$5.2K ﹤0.01% 655
2018
Q2 		$29K Buy
1,313
+550
+72% +$11.2K ﹤0.01% 669
2018
Q1 		$13K Sell
763
-1,914
-71% -$37.4K ﹤0.01% 863
2017
Q4 		$51K Sell
2,677
-771
-22% -$11.6K 0.01% 465
2017
Q3 		$61K Buy
+3,448
New +$77.6K 0.01% 377

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Valeo Financial Advisors's TEVA Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 6,456 shares — an estimated $75K sold.

Valeo Financial Advisors first reported a position in TEVA in Q3 2017 and held it in 15 quarters. The position peaked at $76K in Q4 2020. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 6,456 Teva Pharmaceuticals shares in Q2 2021, an estimated $75K.
  • Valeo Financial Advisors first reported a position in Teva Pharmaceuticals in Q3 2017 and held it in 15 quarters.
  • Valeo Financial Advisors's Teva Pharmaceuticals position peaked at $76K in Q4 2020.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.